Replies to post #130841 on NanoViricides Inc (NNVC)

[JG36]

The company that paid for the facilities and paid for the work in my example was IBM, not company X. IBM owns the trade secrets.

At the Shelton facility Theracour is paying the employees. They are working for Theracour. That NNVC pays Theracour is no more relevant than Proctor & Gamble paying IBM for some computer services -- that doesn't mean they own IBM's trade secrets. NNVC owns neither patents nor trade secrets. The whole point of Theracour was to create an entity owned and controlled by Dr. Diwan that owns all the intellectual property. If you think NNVC gets any of that you are a fool.

[Its_lose_not_loose]

Why don't you ask Seymour and/or Diwan?

Ha! I know, right? That is such a stupid question because we all know you'd never get an answer. My apologies.

[NewMoney]

The only intellectual property here is an idea to cure all viruses known to humankind with a magical nano platform which has failed miserably. And NNVC doesn't even own the rights to it.

Shareholders have been fleeced. :-(

[arvitar]

Two ingredients are lacking for there to be "trade secrets".

- First, there is nothing of commercial value (i.e. PROFITABLE) to protect by a trade secret.

- Second, in the imaginary universe in which NNVC gets a product to market in ten or twenty years from now, a "trade secret" doesn't stop the best minds in well-funded pharma from doing it better and entering the market. In stark contrast, a live patent would stop others from entering the market.

Ergo, the "trade secret" excuse is just another attempt by Seymour to swindle the investing public into believing that Diwan's worthless aging patent isn't of concern.